117 related articles for article (PubMed ID: 26152922)
1. Targeting MYC Translation in Colorectal Cancer.
Castell A; Larsson LG
Cancer Discov; 2015 Jul; 5(7):701-3. PubMed ID: 26152922
[TBL] [Abstract][Full Text] [Related]
2. Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer.
Wiegering A; Uthe FW; Jamieson T; Ruoss Y; Hüttenrauch M; Küspert M; Pfann C; Nixon C; Herold S; Walz S; Taranets L; Germer CT; Rosenwald A; Sansom OJ; Eilers M
Cancer Discov; 2015 Jul; 5(7):768-781. PubMed ID: 25934076
[TBL] [Abstract][Full Text] [Related]
3. Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.
Zhang X; Bi C; Lu T; Zhang W; Yue T; Wang C; Tian T; Zhang X; Huang Y; Lunning M; Hao X; Brown LE; Devine WG; Vose J; Porco JA; Fu K
Leukemia; 2020 Jan; 34(1):138-150. PubMed ID: 31171817
[TBL] [Abstract][Full Text] [Related]
4. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc.
Yu Y; Guo M; Wei Y; Yu S; Li H; Wang Y; Xu X; Cui Y; Tian J; Liang L; Peng K; Liu T
Oncotarget; 2016 Dec; 7(49):80888-80900. PubMed ID: 27825133
[TBL] [Abstract][Full Text] [Related]
5. Translation initiation in colorectal cancer.
Parsyan A; Hernández G; Meterissian S
Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
[TBL] [Abstract][Full Text] [Related]
6. Targeting Myc-driven stress addiction in colorectal cancer.
Saeed H; Leibowitz BJ; Zhang L; Yu J
Drug Resist Updat; 2023 Jul; 69():100963. PubMed ID: 37119690
[TBL] [Abstract][Full Text] [Related]
7. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
9. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
10. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.
Abaza MS; Al-Saffar A; Al-Sawan S; Al-Attiyah R
Tumour Biol; 2008; 29(5):287-303. PubMed ID: 18802399
[TBL] [Abstract][Full Text] [Related]
11. Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia.
Oh ET; Kim CW; Kim HG; Lee JS; Park HJ
Theranostics; 2017; 7(14):3415-3431. PubMed ID: 28912885
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
13. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
[TBL] [Abstract][Full Text] [Related]
14. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
15. Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation.
Itoua Maïga R; Cencic R; Chu J; Waller DD; Brown LE; Devine WG; Zhang W; Sebag M; Porco JA; Pelletier J
Sci Rep; 2019 Feb; 9(1):1265. PubMed ID: 30718665
[TBL] [Abstract][Full Text] [Related]
16. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.
Satoh K; Yachida S; Sugimoto M; Oshima M; Nakagawa T; Akamoto S; Tabata S; Saitoh K; Kato K; Sato S; Igarashi K; Aizawa Y; Kajino-Sakamoto R; Kojima Y; Fujishita T; Enomoto A; Hirayama A; Ishikawa T; Taketo MM; Kushida Y; Haba R; Okano K; Tomita M; Suzuki Y; Fukuda S; Aoki M; Soga T
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7697-E7706. PubMed ID: 28847964
[TBL] [Abstract][Full Text] [Related]
17. NEK8 regulates colorectal cancer progression via phosphorylating MYC.
Cao B; Zhang K; Pan C; Dong Y; Lu F
Cell Commun Signal; 2023 Aug; 21(1):209. PubMed ID: 37596667
[TBL] [Abstract][Full Text] [Related]
18. [Expression of Runx3 and C-myc in human colorectal cancer].
Zheng W; Zheng K; Zhong L; Li Q; Huang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1042-7. PubMed ID: 25057081
[TBL] [Abstract][Full Text] [Related]
19. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
[TBL] [Abstract][Full Text] [Related]
20. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]